Quantbot Technologies LP Invests $2.34 Million in Equifax, Inc. $EFX

Quantbot Technologies LP purchased a new stake in Equifax, Inc. (NYSE:EFX) during the second quarter, according to its most recent disclosure with the SEC. The firm purchased 9,034 shares of the credit services provider’s stock, valued at approximately $2,343,000.

Several other large investors also recently bought and sold shares of EFX. Texas Capital Bank Wealth Management Services Inc lifted its position in shares of Equifax by 3.7% in the first quarter. Texas Capital Bank Wealth Management Services Inc now owns 1,134 shares of the credit services provider’s stock valued at $276,000 after acquiring an additional 40 shares in the last quarter. CX Institutional lifted its holdings in Equifax by 0.9% in the 2nd quarter. CX Institutional now owns 5,005 shares of the credit services provider’s stock valued at $1,298,000 after purchasing an additional 43 shares in the last quarter. Accretive Wealth Partners LLC lifted its holdings in Equifax by 1.1% in the 2nd quarter. Accretive Wealth Partners LLC now owns 4,564 shares of the credit services provider’s stock valued at $1,184,000 after purchasing an additional 48 shares in the last quarter. Sowell Financial Services LLC boosted its stake in Equifax by 4.0% during the 2nd quarter. Sowell Financial Services LLC now owns 1,433 shares of the credit services provider’s stock worth $372,000 after purchasing an additional 55 shares during the last quarter. Finally, Brighton Jones LLC grew its holdings in shares of Equifax by 1.6% during the second quarter. Brighton Jones LLC now owns 3,723 shares of the credit services provider’s stock worth $966,000 after buying an additional 58 shares in the last quarter. 96.20% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

EFX has been the topic of a number of recent research reports. Morgan Stanley restated an “overweight” rating on shares of Equifax in a research report on Friday, October 3rd. Wells Fargo & Company decreased their target price on shares of Equifax from $300.00 to $285.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 15th. Bank of America lowered their target price on Equifax from $285.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, October 3rd. Oppenheimer began coverage on Equifax in a report on Monday, October 13th. They issued an “outperform” rating and a $271.00 price target for the company. Finally, UBS Group boosted their price objective on Equifax from $287.00 to $297.00 and gave the stock a “buy” rating in a research note on Monday, September 15th. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $277.13.

Equifax Stock Up 0.1%

EFX stock opened at $211.50 on Friday. The firm has a market cap of $25.89 billion, a PE ratio of 40.13, a PEG ratio of 2.37 and a beta of 1.59. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.74 and a current ratio of 0.74. The firm’s 50 day moving average price is $220.53 and its 200-day moving average price is $242.97. Equifax, Inc. has a one year low of $199.98 and a one year high of $281.07.

Equifax (NYSE:EFX) last issued its quarterly earnings data on Tuesday, October 21st. The credit services provider reported $2.04 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.10. Equifax had a return on equity of 19.28% and a net margin of 11.08%.The company had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.52 billion. During the same period in the prior year, the business posted $1.85 earnings per share. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. Equifax has set its Q4 2025 guidance at 1.980-2.080 EPS and its FY 2025 guidance at 7.550-7.650 EPS. On average, equities research analysts anticipate that Equifax, Inc. will post 7.58 EPS for the current year.

Equifax Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Monday, November 24th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, November 24th. Equifax’s payout ratio is 37.95%.

Insider Transactions at Equifax

In other news, EVP Jamil Farshchi sold 4,925 shares of the business’s stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $238.94, for a total value of $1,176,779.50. Following the sale, the executive vice president directly owned 39,364 shares of the company’s stock, valued at approximately $9,405,634.16. The trade was a 11.12% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Mark W. Begor sold 27,959 shares of the company’s stock in a transaction that occurred on Monday, October 27th. The stock was sold at an average price of $231.10, for a total transaction of $6,461,324.90. Following the completion of the transaction, the chief executive officer owned 142,934 shares in the company, valued at approximately $33,032,047.40. This represents a 16.36% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 54,270 shares of company stock worth $12,580,837 in the last ninety days. 1.40% of the stock is currently owned by corporate insiders.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.